[HTML][HTML] Dataset used in the economic evaluation trastuzumab-based regimens for HER-2 positive metastatic breast cancer patients in the Taiwanese healthcare …
V Diaby, CY Wang, H Alqhtani… - Data in brief, 2020 - Elsevier
Data in brief, 2020•Elsevier
The present data article aims to describe the input parameters for a Markov model assessing
the cost-effectiveness of four treatment sequences for patients with HER-2 positive
metastatic breast cancer. The model input parameters include costs for physician visits,
drugs, adverse event management, computed tomography (CT) scan, laboratory tests,
echocardiogram, utilities, disutilities as well as the shape and scale parameters of a log-
logistic distribution used for the transition probabilities.
the cost-effectiveness of four treatment sequences for patients with HER-2 positive
metastatic breast cancer. The model input parameters include costs for physician visits,
drugs, adverse event management, computed tomography (CT) scan, laboratory tests,
echocardiogram, utilities, disutilities as well as the shape and scale parameters of a log-
logistic distribution used for the transition probabilities.
Abstract
The present data article aims to describe the input parameters for a Markov model assessing the cost-effectiveness of four treatment sequences for patients with HER-2 positive metastatic breast cancer. The model input parameters include costs for physician visits, drugs, adverse event management, computed tomography (CT) scan, laboratory tests, echocardiogram, utilities, disutilities as well as the shape and scale parameters of a log-logistic distribution used for the transition probabilities.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果